Summerset Group Holdings Ltd (ASX: SNZ) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
Summerset Group Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Summerset Group Holdings Ltd (ASX: SNZ)
Latest News

Healthcare Shares
Macquarie's top 3 ASX stock picks in the healthcare sector

Share Market News
Here are the top 10 ASX shares today

Share Market News
Here are the top 10 ASX shares today
Share Market News
Here are the top 10 ASX shares today
Share Market News
Here are the top 10 ASX shares today
Share Market News
Here are the top 10 ASX 200 shares on Thursday – yes there were some

Share Market News
Why the Summerset (ASX:SNZ) share price is in focus

Share Market News
Retirement village operator Summerset Group's (ASX:SNZ) share price stagnant on property update

Share Market News
Why the Summerset (ASX:SNZ) share price is in focus today
Coronavirus News
ASX records best session in 40 years
Share Market News
Results: Retirement village operator Summerset posts $48 million profit
Healthcare Shares
Summerset Group Holdings Ltd (ASX:SNZ) profit up 26%
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
13 Mar 2025 | $0.1013 | 0.00% | Final | 27 Mar 2025 |
06 Sep 2024 | $0.0888 | 0.00% | Interim | 20 Sep 2024 |
08 Mar 2024 | $0.1320 | 0.00% | Final | 22 Mar 2024 |
05 Sep 2023 | $0.0885 | 0.00% | Interim | 19 Sep 2023 |
09 Mar 2023 | $0.0914 | 0.00% | Final | 23 Mar 2023 |
05 Sep 2022 | $0.0816 | 0.00% | Interim | 19 Sep 2022 |
09 Mar 2022 | $0.0683 | 0.00% | Final | 23 Mar 2022 |
06 Sep 2021 | $0.0807 | 0.00% | Interim | 20 Sep 2021 |
08 Mar 2021 | $0.0554 | 0.00% | Final | 22 Mar 2021 |
28 Aug 2020 | $0.0466 | 0.00% | Interim | 11 Sep 2020 |
09 Mar 2020 | $0.0628 | 0.00% | Final | 23 Mar 2020 |
26 Aug 2019 | $0.0513 | 0.00% | Interim | 09 Sep 2019 |
07 Mar 2019 | $0.0590 | 0.00% | Final | 21 Mar 2019 |
27 Aug 2018 | $0.0465 | 0.00% | Interim | 10 Sep 2018 |
08 Mar 2018 | $0.0563 | 0.00% | Final | 22 Mar 2018 |
28 Aug 2017 | $0.0303 | 0.00% | Interim | 11 Sep 2017 |
08 Mar 2017 | $0.0398 | 0.00% | Final | 22 Mar 2017 |
26 Aug 2016 | $0.0212 | 0.00% | Interim | 09 Sep 2016 |
08 Mar 2016 | $0.0263 | 0.00% | Final | 24 Mar 2016 |
21 Aug 2015 | $0.0142 | 0.00% | Interim | 07 Sep 2015 |
06 Mar 2015 | $0.0170 | 0.00% | Final | 25 Mar 2015 |
22 Aug 2014 | $0.0107 | 0.00% | Interim | 08 Sep 2014 |
07 Mar 2014 | $0.0259 | 0.00% | Final | 24 Mar 2014 |
SNZ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|
About Summerset Group Holdings Ltd
Summerset Group Holdings Ltd develops, owns, and operates integrated retirement villages. The company receives a majority of its revenue from the New Zealand Ministry of Health, which subsidizes fees for eligible aged-care residents. Its revenue is primarily derived from care fees and village services income. Summerset provides a range of care for its residents, including in-home care and 24-hour medical care centers. In addition to its independent-living villas and apartments, Summerset offers supported-living residences, which include assistance with daily activities like shopping and housekeeping.
SNZ Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
24 Apr 2025 | $10.50 | $-0.01 | -0.10% | 7 | $10.51 | $10.51 | $10.50 |
23 Apr 2025 | $10.51 | $0.00 | 0.00% | 12 | $10.51 | $10.51 | $10.51 |
22 Apr 2025 | $10.51 | $0.00 | 0.00% | 307 | $10.51 | $10.51 | $10.51 |
17 Apr 2025 | $10.51 | $0.01 | 0.10% | 92 | $10.50 | $10.51 | $10.50 |
16 Apr 2025 | $10.50 | $0.40 | 3.96% | 165 | $10.50 | $10.50 | $10.50 |
15 Apr 2025 | $10.10 | $-0.35 | -3.35% | 2,938 | $10.45 | $10.55 | $10.10 |
14 Apr 2025 | $10.45 | $0.35 | 3.47% | 42 | $10.45 | $10.45 | $10.45 |
11 Apr 2025 | $10.10 | $-0.07 | -0.69% | 276 | $10.10 | $10.50 | $10.10 |
10 Apr 2025 | $10.17 | $0.28 | 2.83% | 1,040 | $10.04 | $10.28 | $10.04 |
09 Apr 2025 | $9.89 | $-0.30 | -2.94% | 145 | $9.18 | $9.89 | $9.18 |
08 Apr 2025 | $10.19 | $0.12 | 1.19% | 20 | $10.09 | $10.19 | $10.09 |
07 Apr 2025 | $10.07 | $-0.13 | -1.27% | 107 | $10.00 | $10.07 | $10.00 |
03 Apr 2025 | $10.20 | $0.01 | 0.10% | 2 | $10.19 | $10.20 | $10.19 |
02 Apr 2025 | $10.19 | $0.01 | 0.10% | 21 | $10.19 | $10.19 | $10.19 |
01 Apr 2025 | $10.18 | $0.05 | 0.49% | 487 | $10.20 | $10.20 | $10.17 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
27 Mar 2025 | Grainne Troute | Issued | 207 | $2,315 |
Dividend Reinvestment Plan (DRP).
|
27 Mar 2025 | Marie Bismark | Issued | 255 | $2,852 |
Dividend Reinvestment Plan (DRP).
|
27 Mar 2025 | Fiona Oliver | Issued | 86 | $961 |
Dividend Reinvestment Plan (DRP).
|
27 Mar 2025 | Venasio (Vena) Crawley | Issued | 35 | $391 |
Dividend Reinvestment Plan (DRP). As per announcement on 03-04-2025
|
20 Sep 2024 | Grainne Troute | Issued | 172 | $1,975 |
Dividend Reinvestment Plan (DRP). As per announcement on 25-09-2024, NZD
|
20 Sep 2024 | Venasio (Vena) Crawley | Issued | 28 | $321 |
Dividend Reinvestment Plan (DRP). As per announcement on 25-09-2024, NZD$
|
20 Sep 2024 | Fiona Oliver | Issued | 71 | $815 |
Dividend Reinvestment Plan (DRP). NZ$, As per announcement on 25-09-2024
|
20 Sep 2024 | Marie Bismark | Issued | 211 | $2,423 |
Dividend Reinvestment Plan (DRP). NZD$, as per announcement on 25-09-2024
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Mark Verbiest | Non-Executive ChairmanNon-Executive Director | Jul 2021 |
Mr Verbiest is an experienced professional company director with over a decade of experience. A lawyer by training, he spent years in private practice as partner of a national law firm. He subsequently joined the senior executive team at Telecom New Zealand as Group General Counsel, also having executive responsibility for other corporate groups as well as two business units. He is also currently the Chair of listed company Meridian Energy. Mark has previously been Chair of Freightways, Spark, Transpower NZ, Willis Bond Capital and a director of a number of other companies and entities, including ANZ Bank, the inaugural board of the Financial Markets Authority and the advisory board to NZ Treasury. He is member of People and Culture Committee, Development and Construction Committee and member of Risk Committee.
|
Ms Grainne Troute | Non-Executive Director | Sep 2016 |
Ms Troute is a director of Tourism Holdings and Investore Property, and a board member of Duncan Cotterill. Grainne is a professional director with years of experience in senior executive roles. She was General Manager, Corporate Services at SKYCITY Entertainment Group. She also held senior management roles with Coopers and Lybrand (now PwC) and HR Consultancy Right Management. Grainne has expertise in operating customer-focused businesses in competitive sectors. She has also spent years as a trustee and Chair in the not-for-profit sector, including having been the Chair of Tourism Industry Aotearoa (TIA) and Chair of Ronald McDonald House Charities New Zealand. She is Chair of People and Culture Committee and member of member of Risk Committee and Clinical Governance Committee.
|
Dr Marie Bismark | Non-Executive Director | Sep 2013 |
Dr Bismark is Chair of Clinical Governance Committee. Marie works as a Consultant Psychiatrist at Te Whatu Ora, Capital & Coast, and as a Professor at Melbourne University. Her research focuses on patients' rights, quality of care, and medical regulation. Marie is an experienced company director, serving on the boards of GMHBA Health Insurance, The Royal Women's Hospital in Melbourne, and on the Veterans' Health Advisory Panel. Marie is member of People and Culture Committee
|
Ms Fiona Ann Oliver | Non-Executive Director | Mar 2023 |
Ms Oliver is an experienced professional director with a governance career spanning a variety of sectors, including renewable energy, natural gas, technology, commercial property, financial services, professional services, and sport. These roles ranging from Board Member to Audit & Risk Committee Chair, have been in commercial, public sector and not-for-profit entities including, Clarus (formerly First Gas group), and Tilt Renewables. Fiona has held Executive leadership roles in funds management for Westpac (BT Funds Management) and AMP in New Zealand. She has also held commercial roles in asset management and private equity in Sydney and London. Prior to her management career, Fiona practised as a senior corporate and commercial lawyer in New Zealand and overseas, in mergers and acquisitions. She is the Chair of Risk Committee and member of Development and Construction Committee.
|
Dr Andrew Wong | Non-Executive Director | Mar 2017 |
Dr Wong is the Managing Director of HealthCare Holdings Ltd, a private healthcare investment company. He has experience in strategic planning and implementation, business development, leadership and operational management. This has been gained over a 30 year career in public and private health both in New Zealand and overseas. He is a director of a number of companies through his HealthCare Holdings role. These include Auckland Radiation Oncology, MercyAscot hospitals, Kensington Hospital and Mercy Radiology. Other present and past directorships include companies providing services in the areas of interventional cardiology, healthcare property development, medical supplies, day and inpatient surgery and endoscopy, and veterinary medicine. He has held government appointments with Health Workforce New Zealand and the Health Innovation Hub, as well as sitting on the Executive of the New Zealand Private Hospitals Association. Andrew is an Adjunct Professor of AUT. He is member of Clinical Governance Committee and Development and Construction Committee.
|
Mr Venasio (Vena) Lorenzo Crawley | Non-Executive Director | Feb 2020 |
Mr Crawley has career experience in multiple sectors that include banking & financial services, oil & energy, health, education and retail. He is an independent director at Orion NZ, and Chair of the AUT Business School Industry Advisory Board. He also completed a term as a Future Director for The Warehouse Group. Venasio-Lorenzo completed his executive career as the Chief Customer Officer at Contact Energy with the turnaround of their Retail, LPG, Broadband, and Commercial and Industrial businesses. He has international experience working in the United Kingdom, Australia and NZ markets and has skills in profit growth strategy, transformation, technology, digital, data monetisation, operations, logistics, marketing and his passion - customer experience. He is member of People and Culture Committee, Development and Construction Committee and member of Risk Committee and Clinical Governance Committee.
|
Mr Stephen Bull | Non-Executive Director | Mar 2022 |
Mr Bull has over 25 years' experience in real estate, community creation and finance roles. He has held executive roles at Westfield, AMP and Stockland. Stephen finished executive work in 2018 and for the last five years of his executive career was a Group Executive at Stockland and CEO of their retirement village business. Prior to his real estate career in Australia, Stephen spent several years working in investment banking in London. He is currently Chair of Bridge Housing Ltd and Capital Prudential Diversified Development Fund Pty Ltd, a Board Member of the ACT Government City Renewal Authority and an Independent Member of the MaxCap Equity Investment Committee. He is the Chair of Development and Construction Committee and a member of the Risk Committee.
|
Ms Robyn Heyman | Company Secretary |
-
|
|
Mr Scott Scoullar | Chief Executive Officer | Mar 2021 |
-
|
Sarah Theodore | Acting Chief Financial Officer |
-
|
|
Dean Tallentire | Chief Construction Officer New Zealand |
-
|
|
Aaron Smail | Chief Development Officer New Zealand |
-
|
|
Rob Gillespie | Chief Digital Officer |
-
|
|
Scott Scoullar | Chief Executive Officer |
-
|
|
Kay Brodie | Chief Marketing Officer |
-
|
|
Stewart Scott | Chief Operating Officer Australia |
-
|
|
Eleanor Young | Chief Operating Officer New Zealand |
-
|
|
Chris Lokum | Chief People Officer |
-
|
|
Fay French | Chief Sales Officer |
-
|
|
Robyn Heyman | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Custodial Services Limited | 24,675,020 | 10.42% |
HSBC Nominees (New Zealand) Limited | 20,707,696 | 8.74% |
Tea Custodians Limited | 20,292,916 | 8.57% |
BNP Paribas Nominees NZ Limited (BPSS40) | 19,699,086 | 8.32% |
Citibank Nominees (NZ) Ltd | 17,755,037 | 7.50% |
New Zealand Superannuation Fund Nominees Limited | 12,476,328 | 5.27% |
JPMORGAN Chase Bank | 9,154,822 | 3.87% |
Forsyth Barr Custodians Limited | 7,827,401 | 3.31% |
FNZ Custodians Limited | 7,100,353 | 3.00% |
Accident Compensation Corporation | 7,023,205 | 2.97% |
New Zealand Depository Nominee | 4,749,448 | 2.01% |
JBWere (NZ) Nominees Limited | 4,591,685 | 1.94% |
New Zealand Permanent Trustees Limited | 4,293,882 | 1.81% |
HSBC Nominees (New Zealand) Limited i | 3,654,611 | 1.54% |
Premier Nominees Limited | 3,495,027 | 1.48% |
Public Trust | 2,495,854 | 1.05% |
Pt Booster Investments Nominees Limited | 2,440,047 | 1.03% |
BNP Paribas Nominees (NZ) Limited | 2,393,130 | 1.01% |
JP Morgan Nominees Australia Pty Limited | 1,937,631 | 0.82% |
NZ Permanent Trustees Ltd Grp Invstmnt Fund No 20 | 1,776,226 | 0.75% |